Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A botanical, phytochemical and ethnomedicinal review of the genus Mitragyna korth: Implications for products sold as kratom
Paula N. Brown, Jensen A. Lund, Susan J. Murch
Journal of Ethnopharmacology (2017) Vol. 202, pp. 302-325
Closed Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations
Christopher R. McCurdy, Abhisheak Sharma, Kirsten E. Smith, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 2, pp. 131-142
Closed Access | Times Cited: 18
Kratom—Pharmacology, Clinical Implications, and Outlook: A Comprehensive Review
Steven Eastlack, Elyse M. Cornett, Alan D. Kaye
Pain and Therapy (2020) Vol. 9, Iss. 1, pp. 55-69
Open Access | Times Cited: 138
<p>Current perspectives on the impact of Kratom use</p>
Charles A. Veltri, Oliver Grundmann
Substance Abuse and Rehabilitation (2019) Vol. Volume 10, pp. 23-31
Open Access | Times Cited: 127
Kratom as a substitute for opioids: Results from an online survey
Marion A. Coe, Janine L. Pillitteri, Mark A. Sembower, et al.
Drug and Alcohol Dependence (2019) Vol. 202, pp. 24-32
Closed Access | Times Cited: 123
Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program
Kirsten E. Smith, Thomas Lawson
Drug and Alcohol Dependence (2017) Vol. 180, pp. 340-348
Closed Access | Times Cited: 116
Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions
Daniel A. Todd, Joshua J. Kellogg, E. Diane Wallace, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 97
The Chemistry of Kratom [Mitragyna speciosa]: Updated Characterization Data and Methods to Elucidate Indole and Oxindole Alkaloids
Laura Flores‐Bocanegra, Huzefa A. Raja, Tyler N. Graf, et al.
Journal of Natural Products (2020) Vol. 83, Iss. 7, pp. 2165-2177
Open Access | Times Cited: 86
Characteristics of deaths associated with kratom use
John Corkery, Peter Streete, Hugh Claridge, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 9, pp. 1102-1123
Open Access | Times Cited: 84
Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users
Darshan Singh, Nelson Jeng‐Yeou Chear, Suresh Narayanan, et al.
Journal of Ethnopharmacology (2019) Vol. 249, pp. 112462-112462
Closed Access | Times Cited: 79
Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use
Kirsten E. Smith, Jeffrey M. Rogers, Destiny Schriefer, et al.
Drug and Alcohol Dependence (2021) Vol. 226, pp. 108879-108879
Open Access | Times Cited: 56
Understanding Kratom Use: A Guide for Healthcare Providers
Marc T. Swogger, Kirsten E. Smith, Albert Garcia‐Romeu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 52
Human Mitragynine and 7-Hydroxymitragynine Pharmacokinetics after Single and Multiple Daily Doses of Oral Encapsulated Dried Kratom Leaf Powder
Marilyn A. Huestis, Martin A. Brett, J. Bothmer, et al.
Molecules (2024) Vol. 29, Iss. 5, pp. 984-984
Open Access | Times Cited: 13
Kratom safety and toxicology in the public health context: research needs to better inform regulation
Jack E. Henningfield, Oliver Grundmann, Marilyn A. Huestis, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 11
Kratom Withdrawal: A Systematic Review with Case Series
Cornel N. Stanciu, Samantha A. Gnanasegaram, Saeed Ahmed, et al.
Journal of Psychoactive Drugs (2019) Vol. 51, Iss. 1, pp. 12-18
Closed Access | Times Cited: 64
G protein‐biased kratom‐alkaloids and synthetic carfentanil‐amide opioids as potential treatments for alcohol use disorder
Anna M. Gutridge, Meridith T. Robins, Robert J. Cassell, et al.
British Journal of Pharmacology (2019) Vol. 177, Iss. 7, pp. 1497-1513
Open Access | Times Cited: 64
Exploring the Chemistry of Alkaloids from Malaysian Mitragyna speciosa (Kratom) and the Role of Oxindoles on Human Opioid Receptors
Nelson Jeng‐Yeou Chear, Francisco León, Abhisheak Sharma, et al.
Journal of Natural Products (2021) Vol. 84, Iss. 4, pp. 1034-1043
Open Access | Times Cited: 55
Activity of Mitragyna speciosa (“Kratom”) Alkaloids at Serotonin Receptors
Francisco León, Samuel Obeng, Marco Mottinelli, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 18, pp. 13510-13523
Open Access | Times Cited: 51
A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects
Soumen Chakraborty, Jeffrey F. DiBerto, Abdelfattah Faouzi, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 18, pp. 13873-13892
Open Access | Times Cited: 50
Oxidative Metabolism as a Modulator of Kratom’s Biological Actions
Soumen Chakraborty, Rajendra Uprety, Samuel T. Slocum, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 22, pp. 16553-16572
Open Access | Times Cited: 43
The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review
Thiruventhan Karunakaran, Kok Zhuo Ngew, Ahmad Alif Danial Zailan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 29
Antidiabetic and antioxidant activities of Mitragyna speciosa (kratom) leaf extract in type 2 diabetic rats
Pengpeng Zhang, Wei Wei, Xiaohai Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114689-114689
Open Access | Times Cited: 16
Motives for using Kratom (Mitragyna speciosa Korth.) among regular users in Malaysia
Darshan Singh, Suresh Narayanan, Christian P. Müller, et al.
Journal of Ethnopharmacology (2018) Vol. 233, pp. 34-40
Closed Access | Times Cited: 54
Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs
Zurina Hassan, Oliver G. Bosch, Darshan Singh, et al.
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 52
Plant science decadal vision 2020–2030: Reimagining the potential of plants for a healthy and sustainable future
Natalie Henkhaus, Madelaine Bartlett, David R. Gang, et al.
Plant Direct (2020) Vol. 4, Iss. 8
Open Access | Times Cited: 46
Evaluation of the Mitragynine Content, Levels of Toxic Metals and the Presence of Microbes in Kratom Products Purchased in the Western Suburbs of Chicago
Walter C. Prozialeck, Joshua R. Edwards, Peter C. Lamar, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 15, pp. 5512-5512
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top